112 related articles for article (PubMed ID: 8931421)
21. Antiretroviral treatment regimens and immune parameters in the prevention of systemic AIDS-related non-Hodgkin's lymphoma.
Stebbing J; Gazzard B; Mandalia S; Teague A; Waterston A; Marvin V; Nelson M; Bower M
J Clin Oncol; 2004 Jun; 22(11):2177-83. PubMed ID: 15169806
[TBL] [Abstract][Full Text] [Related]
22. AIDS-related lymphoma.
Tulpule A; Levine A
Blood Rev; 1999 Sep; 13(3):147-50. PubMed ID: 10527266
[TBL] [Abstract][Full Text] [Related]
23. Hodgkin's and non-Hodgkin's lymphoma of the head and neck.
Urquhart A; Berg R
Laryngoscope; 2001 Sep; 111(9):1565-9. PubMed ID: 11568605
[TBL] [Abstract][Full Text] [Related]
24. [Treatment of aggressive non-Hodgkin's lymphoma with the ProMACE- CytaBOM protocol].
Mihaljević B; Jancić-Nedeljkov R; Sretenović M; Milivojević G; Janković S; Petrović M
Srp Arh Celok Lek; 1998; 126(9-10):345-8. PubMed ID: 9863405
[TBL] [Abstract][Full Text] [Related]
25. Descriptive epidemiology of gastrointestinal non-Hodgkin's lymphoma in a population-based registry.
Gurney KA; Cartwright RA; Gilman EA
Br J Cancer; 1999 Apr; 79(11-12):1929-34. PubMed ID: 10206316
[TBL] [Abstract][Full Text] [Related]
26. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
[TBL] [Abstract][Full Text] [Related]
27. [Primary gastrointestinal non-Hodgkin's lymphomas].
Nedeljkov R; Mihaljević B; Milivojević G; Janković S; Jovanović V; Petrović M
Srp Arh Celok Lek; 1992; 120(9-10):289-91. PubMed ID: 1306022
[TBL] [Abstract][Full Text] [Related]
28. GI-lymphomas in immunosuppressed patients (organ transplantation; HIV).
Heise W
Best Pract Res Clin Gastroenterol; 2010 Feb; 24(1):57-69. PubMed ID: 20206109
[TBL] [Abstract][Full Text] [Related]
29. Factors associated with the occurrence of AIDS-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: Aquitaine Cohort, France.
Bonnet F; Balestre E; Thiébaut R; Morlat P; Pellegrin JL; Neau D; Dabis F;
Clin Infect Dis; 2006 Feb; 42(3):411-7. PubMed ID: 16392091
[TBL] [Abstract][Full Text] [Related]
30. Combined modality treatment for primary gastrointestinal non-Hodgkin's lymphoma: the Milan Cancer Institute experience.
Tondini C; Giardini R; Bozzetti F; Valagussa P; Santoro A; Bertulli R; Balzarotti M; Rocca A; Lombardi F; Ferreri AJ
Ann Oncol; 1993 Dec; 4(10):831-7. PubMed ID: 8117602
[TBL] [Abstract][Full Text] [Related]
31. The International Prognostic Index can be used as a guide to treatment decisions regarding patients with human immunodeficiency virus-related systemic non-Hodgkin lymphoma.
Rossi G; Donisi A; Casari S; Re A; Cadeo G; Carosi G
Cancer; 1999 Dec; 86(11):2391-7. PubMed ID: 10590382
[TBL] [Abstract][Full Text] [Related]
32. Serum soluble CD23 level correlates with subsequent development of AIDS-related non-Hodgkin's lymphoma.
Schroeder JR; Saah AJ; Hoover DR; Margolick JB; Ambinder RF; Martinez-Maza O; Breen EC; Jacobson LP; Variakojis D; Rowe DT; Armenian HK
Cancer Epidemiol Biomarkers Prev; 1999 Nov; 8(11):979-84. PubMed ID: 10566552
[TBL] [Abstract][Full Text] [Related]
33. Liposome-encapsulated doxorubicin in combination with standard agents (cyclophosphamide, vincristine, prednisone) in patients with newly diagnosed AIDS-related non-Hodgkin's lymphoma: results of therapy and correlates of response.
Levine AM; Tulpule A; Espina B; Sherrod A; Boswell WD; Lieberman RD; Nathwani BN; Welles L
J Clin Oncol; 2004 Jul; 22(13):2662-70. PubMed ID: 15226333
[TBL] [Abstract][Full Text] [Related]
34. AIDS-related non-Hodgkin's lymphoma of the pancreas.
Jones WF; Sheikh MY; McClave SA
Am J Gastroenterol; 1997 Feb; 92(2):335-8. PubMed ID: 9040219
[TBL] [Abstract][Full Text] [Related]
35. Epidemiology of HIV associated non-Hodgkin lymphoma.
Obrams GI; Grufferman S
Cancer Surv; 1991; 10():91-102. PubMed ID: 1821326
[TBL] [Abstract][Full Text] [Related]
36. [Paraproteins and lymphoma in HIV positive patients].
Drees C; Postler C; Schwonzen M; Diehl V; Gause A
Med Klin (Munich); 1996 Apr; 91(4):193-8. PubMed ID: 8692105
[TBL] [Abstract][Full Text] [Related]
37. Increasing incidence rates, distribution and histological characteristics of primary gastrointestinal non-Hodgkin lymphoma in a North American population.
Howell JM; Auer-Grzesiak I; Zhang J; Andrews CN; Stewart D; Urbanski SJ
Can J Gastroenterol; 2012 Jul; 26(7):452-6. PubMed ID: 22803021
[TBL] [Abstract][Full Text] [Related]
38. Primary gastrointestinal non Hodgkin's lymphoma chemotherapy alone an effective treatment modality: experience from a single centre in India.
Raina V; Sharma A; Vora A; Shukla NK; Deo SV; Dawar R
Indian J Cancer; 2006; 43(1):30-5. PubMed ID: 16763360
[TBL] [Abstract][Full Text] [Related]
39. Clinical characteristics of gastrointestinal lymphomas associated with AIDS (GI-ARL) and the impact of HAART.
Srinivasan S; Takeshita K; Holkova B; Czuczman MS; Miller K; Bernstein ZP; Driscoll D; Chanan-Khan A
HIV Clin Trials; 2004; 5(3):140-5. PubMed ID: 15248138
[TBL] [Abstract][Full Text] [Related]
40. Hodgkin lymphoma is as common as non-Hodgkin lymphoma in HIV-positive patients with sustained viral suppression and limited immune deficiency: a prospective cohort study.
Hoffmann C; Hentrich M; Gillor D; Behrens G; Jensen B; Stoehr A; Esser S; van Lunzen J; Krznaric I; Müller M; Oette M; Hensel M; Thoden J; Fätkenheuer G; Wyen C
HIV Med; 2015 Apr; 16(4):261-4. PubMed ID: 25252101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
